Matthew C. Hill - Jan 15, 2025 Form 4 Insider Report for Apyx Medical Corp (APYX)

Role
Chief Financial Officer
Signature
/s/ Matthew C. Hill
Stock symbol
APYX
Transactions as of
Jan 15, 2025
Transactions value $
$0
Form type
4
Date filed
1/17/2025, 04:07 PM
Previous filing
Mar 3, 2025
Next filing
May 19, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APYX Stock Option (Option to Buy) Award $0 +50K $0.00 50K Jan 15, 2025 Common Stock 50K $1.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting person was granted a stock option which shall vest ratably over a thirty-six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.